Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 8, 2024
Abstract
Considering
the
strong
electron‐donating
ability
and
superior
biocompatibility,
integration
of
zero‐valent
iron
nanostructure
Fe
0
(electron‐reservoir)
boron
B
offers
great
promise
for
fabricating
novel
ferroptosis
nanoagents.
Nevertheless,
controlled
facile
synthesis
alloyed
nanostructure‐FeB
nanometallic
glasses
(NMGs)
has
remained
a
long‐standing
challenge.
Herein,
complexion‐reduction
strategy
is
proposed
FeB
NMGs
with
greater
electron
donating
capacity
to
activate
molecular
oxygen
improved
therapy.
In‐depth
mechanism
reveales
that
effectively
prevent
long‐range
diffusion
,
resulting
in
amorphous
nanoparticles
(FeB
NPs).
The
NPs
display
stronger
capability
transfer
rate
9.4
times
higher
than
NPs,
which
produce
∙O
2
−
H
O
∙OH.
vitro
cellular
experiments
confirm
FeB‐ss‐SiO₂
(encapsulation
SiO
outlayer
containing
‐S‐S‐
bonds)
demonstrates
enhanced
ferroptosis.
tumor‐bearing
mice
models
shows
exhibited
biocompatibility
tumor
inhibition
effect
(inhibition
73%),
improve
overall
survival
30
days
post‐treatment.
This
study
will
provide
an
innovative
way
design
therapeutic
nanoagents
cancer
treatments.
Small,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Abstract
Chemodynamic
therapy
(CDT)
has
garnered
significant
attention
in
the
field
of
tumor
due
to
its
ability
convert
overexpressed
hydrogen
peroxide
(H
2
O
)
tumors
into
highly
toxic
hydroxyl
radicals
(•OH)
through
metal
ion‐mediated
catalysis.
However,
effectiveness
CDT
is
hindered
by
low
catalyst
efficiency,
insufficient
intra‐tumor
H
level,
and
excessive
glutathione
(GSH).
In
this
study,
a
pH/GSH
dual
responsive
bimetallic
nanocatalytic
system
(CuFeMOF@GOx@Mem)
developed
modifying
red
blood
cell
membranes
onto
glucose
oxidase
(GOx)‐loaded
Fe‐Cu
MOFs,
enhancing
efficacy
triple‐enhanced
way
self‐supply,
catalysts
self‐cycling,
GSH
self‐elimination.
Upon
accumulation
tissues
facilitated
membrane,
GOx
initiates
reaction
with
generate
gluconic
acid
situ.
Subsequently,
reduced
pH
triggers
release
Fe
3+
Cu
2+
from
CuFeMOF@GOx@Mem,
which
immediately
turned
+
GSH,
activating
‐mediated
Fenton
reaction.
More
importantly,
can
also
act
as
an
accelerator
/Fe
conversion,
meanwhile,
generated
be
further
GSH.
Consequently,
sustained
well
elimination
are
achieved
simultaneously,
providing
unique
approach
for
improving
anti‐tumor
CDT.
Advanced Functional Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 21, 2025
Abstract
A
Mn‐anchored
ultrasmall
hydrophilic
TiO
2
based
contrast
agent
(TMn‐PMM)
is
prepared
via
ligand
directed
hydrolysis
with
high
relaxivity
(71.4
mM
−1
s
under
0.5
T,
which
16.7
times
higher
than
that
of
commercial
Gd‐contrast
agents).
Results
indicate
the
presences
ligands
(oleylamine/oleic
acid)
tend
to
obtain
degree
crystallinity
even
after
removal
by
etching,
lead
less
surface
oxygen
vacancy
obtained
ethanol.
The
well‐dispersed
Mn
sites
and
rich
hydroxyl
groups
(O─H)
in
TMn‐PMM
significantly
increase
effective
active
for
interaction
surrounding
water
protons,
addition
extending
rotational
correlation
time
(
τ
R
),
thus,
affording
satisfied
magnetic
resonance
imaging
(MRI)
performance
vivo.
Moreover,
size
zwitterionic
polymer
coating
ensure
excellent
biocompatibility
desirable
body
clearance.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 19, 2025
Magnetic
resonance
imaging
(MRI)
often
employs
contrast
agents
(CAs)
to
improve
the
visualization
of
lesions.
Although
iron-based
oxides
have
been
clinically
approved
as
T2
CAs,
various
obstacles
hindered
their
widespread
commercial
use.
Consequently,
there
is
a
pressing
demand
for
innovative
T2-type
CAs.
Herein,
we
synthesized
an
hydrogen-bonded
organic
framework
(Fe-HOF)
from
Fe-TCPP
and
explored
its
potential
T2-weighted
MRI
CA.
The
Fe-HOF
demonstrated
superior
relaxivity
(r2)
32.067
mM–1
s–1
higher
r2/r1
ratio
45.25
compared
Fe-TCPP.
This
enhancement
may
be
attributed
combination
single-atom
form
Fe3+
with
increased
radius.
Our
findings
indicate
that
6
μmol
[Fe]/kg
dose
significantly
improves
lesion
in
scans
subcutaneous
tumor
model
mice
liver
metastasis
breast
tumor.
simplicity
Fe-HOF'
s
structure
ensures
absence
complex
metal
ions
or
ligands
during
synthesis,
iron
component
can
metabolized
into
endogenous
pool,
resulting
remarkable
biocompatibility
biosafety.
These
pave
way
design
novel
probes
tailored
cancer
characterization
at
stages.
Advanced Functional Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 13, 2025
Abstract
Theranostic
probes
that
integrate
diagnosis
and
treatment
together
are
considered
as
effective
tools
for
individual
therapy.
However,
the
separation
of
detection
components
limits
precise
assessment
therapeutic
efficacy.
Herein,
a
novel
self‐monitoring
probe
sensitively
responds
to
adenosine
triphosphate
(ATP)
was
developed
by
ultrafine
iron
oxide
nanowires
(UIONWs)
through
an
oleyl
amine‐assisted
way.
The
UIONWs,
with
diameter
1.5
nm
length
75
nm,
surface‐coordinated
amine.
UIONWs
can
be
decomposed
in
ATP‐containing
solution
expose
shielded
ions.
Consequently,
it
boost
peroxidase
(POD)
activity
activate
T
1
‐magnetic
resonance
imaging
(MRI)
signal
ATP.
In
addition,
rapidly
engulfed
into
cells
due
high
aspect
ratio.
improved
ATP
hydrogen
peroxide
(H
2
O
)
within
tumor
leads
higher
hydroxyl
radicals
(OH)
generation
inhibition.In
contrast,
normal
exhibit
lower
H
levels,
reducing
cytotoxicity
ensuring
safety.
Since
both
illumination
‐MRI
OH
ATP‐controlled,
this
work
raised
potential
way
self‐monitor
therapy
timely
feedback
on
effects.
Small,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 24, 2025
Abstract
Excellent
multifunctional
platforms
for
cancer
diagnosis
and
treatment
are
highly
desirable.
Herein,
nanocomposites
constructed
by
utilizing
Mn
2+
to
coordinate
the
imidazole
moiety
anchored
on
CuO
2
nanoparticles
through
cyclodextrin‐adamantane
interaction.
The
encapsulated
(NPs)
can
generate
hydrogen
peroxide
(H
O
)
at
tumor
sites
under
acidic
conditions
upon
decomposition,
which
is
further
turned
into
oxygen
(O
catalysis,
facilitating
both
ultrasound
magnetic
resonance
imaging
(MRI).
Moreover,
proposed
nanomedicine
enhances
reactive
species
(ROS)
generation
depletes
glutathione
(GSH),
leading
increased
lipid
peroxidation
(LPO)
effective
ferroptosis‐mediated
therapy.
Such
a
strategy
presents
promising
approach
development
of
theranostics
imaging‐guided
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 30, 2025
Abstract
Self‐supply
of
peroxo
compounds
has
been
regarded
as
a
promising
strategy
to
enhance
Fenton
chemistry‐based
chemodynamic
therapy
(CDT).
However,
the
inherent
selectivity
CDT
will
be
affected
after
introducing
peroxide‐supplementing
functionality
into
agents
due
lack
ability
distinguish
cancer
cells
from
normal
cells.
Here,
an
intelligent
nanomedicine
is
reported
with
both
cascade‐responsive
and
peroxide
self‐supplying
performances
for
specific
efficient
treatment.
Upon
endocytosis
acidic
endo/lysosomes,
comprising
methyl
linoleate
hydroperoxide
(MLH)‐loaded
amorphous
iron
oxide
nanoparticles
(AIO@MLH
NPs)
can
decomposed
release
MLH
Fe
3+
that
further
reduced
2+
by
endo/lysosomal
six‐transmembrane
epithelial
antigen
prostate
(STEAP)
metalloreductase
activity,
enabling
occurrence
Fenton‐type
reaction
between
high‐active
free
radical
generation,
which
causes
damage
cell
apoptosis.
Noteworthily,
AIO@MLH
NPs
exhibit
potent
cytotoxicity
cancerous
rather
than
non‐cancerous
benefiting
overexpressed
STEAP
in
multiple
cancers,
thereby
leading
precise
tumor
CDT.
This
work
highlights
use
endogenous
improve
paves
way
development
precision
medicine.
Photodynamic
therapy
(PDT)
is
widely
utilized
in
cancer
treatment
as
a
noninvasive
strategy.
Phycocyanin
(PC),
natural
water-soluble
photosensitizer
with
nontoxic
properties,
shows
promise
PDT
candidate.
However,
the
limitations
of
PC
when
used
alone
for
treatment,
such
inadequate
tumor
delivery
and
weak
efficacy,
must
be
addressed.
Herein,
an
efficient
theranostic
manganese
(Mn)-based
nanocomplex
(PC@Mn)
was
synthesized
through
straightforward
one-pot
self-assembly
reaction
synergistic
antitumor
therapy.
The
PC@Mn
nanoparticles
were
found
to
have
suitable
size
(∼129
nm)
demonstrated
excellent
biocompatibility
biosafety.
Importantly,
these
exhibited
enhanced
biodistribution
improved
targeting
retention
properties.
When
combined
650
nm
laser
irradiation,
showed
significant
enhancement
effect
vivo.
Additionally,
displayed
promising
magnetic
resonance
(MR)
imaging
capabilities,
high
relaxation
rate
(r1
=
10.14
mM-1
s-1)
extended
time
window
(4
h).
This
feature
enables
real-time
monitoring
nanoparticles'
distribution
within
tumors,
facilitating
precise
determination
optimal
time.
Overall,
study
highlights
simple,
safe,
highly
strategy
Its
ability
combine
MR
guidance
represents
approach
therapeutic
outcomes
potential
clinical
applications
future.